2015 Annual Convention



Similar documents
Specialty Pharmacy. Business Plan. July 8, RUSH University Medical Center

2015 Annual Convention

Specialty Pharmacy Definition

FREQUENTLY ASKED QUESTIONS ABOUT THE CVS CAREMARK PRESCRIPTION DRUG PROGRAM

Overview of the Specialty Drug Trend

Specialty Pharmacy? Disclosure. Objectives Technician

Winter Changing landscapes, pipeline products and plan sponsor impact

5/5/2015 PHARMACY WHAT S AN EMPLOYER TO DO? Current Structure Misaligned

The Basics of Pharmacy Benefits Management (PBM) 2009

scriptsourcing THE NEXT 5 YEARS OF RX COSTS AND HOW THEY WILL IMPACT YOUR BOTTOM LINE ScriptSourcing Prescription Advocacy Services

FREE PRESCRIPTION DISCOUNT CARD AVAILABLE TO WELD COUNTY RESIDENTS

Specialty Pharmacy. Oncology

UHC Branded Specialty Pharmacy Program

Understanding specialty drugs

2015 Annual Convention

Pharmacy Profitability What s Over the Horizon? Don Dietz, R.Ph, MS Vice President, Pharmacy Healthcare Solu;ons, Inc.

SPECIALTY TREND MANAGEMENT

Prescription Drug Utilization and Cost Trends,

Medical School for Actuaries. June 12, Baltimore, Maryland

Specialty Pharmacy: Understanding the Market and Solution. Your Goals. Presented by Chris Brown November 2009

Novel Opportunities for Engagement Utilizing in House Pharmacy Services

2015 Annual Convention

Operation and Management Considerations for Specialty Pharmacy

Medication Therapy Management: Data Exchange

Tips, Tricks and Traps Practical Insights into 340B

Specialty Drug Hyperinflation:

Leveraging Star Ratings in Medicare Within Community Pharmacies

After a decade of relative stability as increasing use of

Thrifty White Pharmacy 9/5/2014. Specialty Pharmacy. Specialty Pharmacy: The Opportunities and the Challenges

MArch The 2014 Drug Trend Report MEDICAID

University of Nebraska Prescription Drug Program 2014

Healthier Patients and a Healthier Bottom Line: Improving Your Pharmacy Practice Through Prescription Adherence Management

Summary. UnitedHealth Center for Health Reform & Modernization 1

PRESCRIPTION MEDICINES: COSTS IN CONTEXT

The High Prices of Prescription Drugs Increase Costs for Everyone

Hepatitis C Virus (HCV)

Managed Care Pharmacy. Objectives. Health Plans Some Background 4/7/2015. Kim Moon, PharmD Spring 2015

The Excelsior Solutions Difference

115 th Annual Convention

Growth in revenue from MS drugs has been driven largely by price increases over the last several years.

Prescription Plan FAQ s

SUPPLEMENT Benefits Enrollment Key Dates. FOR PRE-MEDICARE RETIREES November November 2 Retiree Open Enrollment Begins

Automating Specialty Pharmacy

116th Annual Convention

Ensuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability

Building a Specialty Pharmacy Business. Kyle Skiermont, PharmD Director of Specialty/Infusion Operation Fairview Pharmacy Services

SAVINGS GUARANTEED FEEL BETTER. This Program is NOT Insurance. Membership

Specialty Drug Care: Case management services in Quebec

Arthritis Foundation Position Statement on Biosimilar Substitution

Annual Notice of Changes for 2014

HEPATITIS C THERAPY PRIOR AUTHORIZATION FORM: Page 1 of 3 Patient Information. Diagnosis Acute Hep C Chronic Hep C Hepatocellular Carcinoma

A Patient s Guide to Medicare Part D

drug trend and therapy class review CuraScript Specialty Pharmacy Management Guide & Trend Report

Healthcare Spending Among Privately Insured Individuals Under Age 65

Chapter 422. (House Bill 761) Health Insurance Specialty Drugs

Prescription Drug Plan

Pharmaceutical Marketplace Dynamics Expenditures, Distribution, Coverage, Pricing

Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company

Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data).

Adapting Pharmaceutical Reimbursement Policies to Manage Spending on High-Cost Drugs

Natalie Pons, Senior Vice President, Assistant General Counsel, Health Care Services. CVS Caremark Corporation

Specialty Drug Management Solutions You Haven t Heard Before

Specialty drug program. Save time. Save money. Feel good.

Contents General Information General Information

BE WISE, IMMUNIZE: AN UPDATE ON IMMUNIZATION PRACTICES GRETCHEN KRECKEL GAROFOLI, PHARMD

Specialty Pharmacy in Community Pharmacy: The Time Is Now and How!

First Health Part D Value Plus (PDP) offered by First Health Life & Health Insurance Company

Taking Strategic Partnerships to the Next Level: An Alternative Approach to Licensing Your Development Asset

Make sure you re covered for your biologic medicine!

SPECIALTY DRUGS: IT S ABOUT HEALTH, VALUE AND PRICE

RMIP Prescription Plan FAQ's

RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD

Medicare Part D Plans Deliver Significant Savings on Innovative, Breakthrough Medicines

Main Title slide wording

Pharmacy Outreach Program The University of Rhode Island College of Pharmacy

Certified Specialty Pharmacist (CSP ) Job Analysis Executive Summary

Remove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach

Specialty Drugs: AN EVOLVING COMMERCIAL MODEL

Pharmacy Handbook. Understanding Your Prescription Benefit

Understanding Specialty Pharmacy Management and Cost Control

Integrated Life Cycle Patient Access Solutions that Maximize Brand ROI

Medicare At A Glance. State Health Insurance Assistance Program (SHIP)

Princeton University Prescription Drug Plan Summary Plan Description

Disease Management Identifications and Stratification Health Risk Assessment Level 1: Level 2: Level 3: Stratification

MINIMUM PROGRAM REQUIREMENTS FOR CHILD AND ADOLESCENT HEALTH CENTERS ADOLESCENT SITES

Key Medicare Issues for Coverage and Reimbursement of Specialty Pharmaceuticals

WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES MARK GAROFOLI, PHARMD, MBA, CGP PETE KRECKEL, RPH

REVISING SPECIALTY TIERS

What is an Accountable Care Organization & Why is it Important to Your Home Infusion Company?

PRESCRIPTION DRUG RIDER. Beechcraft

The Rising Tide of Pharmacy Benefit Cost and Complexity: A health plans roadmap to optimizing pharmacy services relationships

Overview of the BCBSRI Prescription Management Program

Lisa Scholz, PharmD, MBA Senior Vice President and Chief Operating Officer 340B Health

GENERAL INFORMATION. With Express Scripts, you have access to:

What is an Accountable Care Organization & Why is it Important to Your Home Infusion Company? Disclosures. Overview 3/10/2015

2015 Medicare Supplement Program

Introduction. Background

June G. Javier, PharmD, BCPS Friday, April 17, 2015

Session 4 Treatment Challenges

Transcription:

2015 Annual Convention Date: Monday, October 12, 2015 Time: 8:00 am 9:30 am Location: Gaylord National Harbor Resort and Convention Center, National Harbor 3 Title: Activity Type: Speaker: How to Create a Specialty Pharmacy Presence for Your Community Pharmacy ACPE # 207-000-15-118-L04-P 0.15 CEUs ACPE # 207-000-15-118-L04-T Application-based Aaron Clark, PharmD, Blount Discount Pharmacy Frank Steed, RPh, Gerould s Pharmacies, Inc. Jonathan Grice, PharmD, HomeTown Pharmacy Kevin Day, PharmD, Executive Resident, NCPA Pharmacist and Pharmacy Technician Learning Objectives: Upon completion of this activity, participants will be able to: 1. Discuss the specialty marketplace, how independent pharmacy fits into the marketplace, and what capabilities are required to participate. 2. Identify barriers to entry for an independent pharmacy looking into specialty pharmacy. 3. Discuss options available for independent pharmacies to obtain capabilities of a specialty pharmacy. Disclosures: Aaron Clark declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria. Frank Steed declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria. Jonathan Grice declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria. Kevin Day declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria. NCPA s education staff declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria. NCPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is accredited by NCPA for 0.15 CEUs (1.5 contact hours) of continuing education credit.

http://www.drugstorenews.com//article/dsntv-ncpaforum-touts-community-pharmacy-role-specialty-rxpart-1?sid=43640 How to Create a Specialty Pharmacy Presence for Your Community Pharmacy Disclosure Kevin Day has no financial conflicts to disclose. Aaron Clark has no financial conflicts to disclose. Frank Steed is a customer of Aureus Health Services. Jonathan Grice is a customer of KloudScript, Inc. These potential conflicts of interest have been resolved by peer review of the slides. 1

Learning Objectives 1. Discuss the specialty marketplace, how independent pharmacy fits into the marketplace, and what capabilities are required to participate. 2. Identify barriers to entry for an independent pharmacy looking into specialty pharmacy. 3. Discuss options available for independent pharmacies to obtain capabilities of a specialty pharmacy. What is Specialty?? Specialty Manufacturers and Payers are defining specialty Manufacturers: Limited Distribution Drugs Closed and Limited Networks Payers: Fourth Tier for Medications Specialty Pharmacy Networks Prior Authorization 2

Specialty In general, Specialty Medications have most of the following characteristics: High cost Indicated for the treatment of a chronic, rare illness Injectable or infused Complex manufacturing Special storage and handling requirements Complex monitoring for patient compliance, persistence, and side effects Many treat Cancer, Multiple Sclerosis, Genetic Disorders, Infectious Diseases, and Auto- Immune/Inflammatory Diseases Specialty SPECIALTY DRUG SPEND AMOUNT AND PERCENT OF TOTAL DRUG SPEND* $300 60% Specialty Drug Spend (billions) $250 $200 $150 $100 30% $92B 38% $127B 45% $179B 50% $235B 50% 40% 30% 20% Percent of Total Drug Spend $50 10% $0 2012 2014** 2016** 2018** *Includes medical and pharmacy benefit spending. **Projected Source: CVS Health. 2014 Insights Report. 2014. http://www.cvshealth.com/2014 insights report specialty drives trend 0% Specialty Pharmacy Specialty pharmacy is a set of services Patient management Adherence support Data collection, aggregation, and reporting Specialty pharmacies have demonstrated the capabilities to efficiently and effectively provide these services 3

Specialty Pharmacy So how does an independent become a specialty pharmacy? You might be able to just call yourself one! More likely Look for a partner Build the capabilities yourself Achieve accreditation Specialty Pharmacy Partners: Several companies are helping independent pharmacies participate in the specialty pharmacy marketplace They offer a variety of solutions for pharmacies Specialty Pharmacy Challenges for Independent Pharmacies Marketing Workflow Staffing Financials Contracting Accreditation 4

Aaron Clark, PharmD Blount Discount Pharmacy aaron@blountdiscountpharmacy.com Quality Care Specialty Program Frank Steed, RPh Gerould s Pharmacy gerouldsws@aol.com What is a Specialty Pharmacy? A pharmacy that manages high cost drugs that often require special handling and additional pharmacy (or clinical) support Many are complex biologics and injectable drugs Specialty drugs are used to treat serious or chronic medical conditions such as: Multiple Sclerosis, Hemophilia, Chronic Hepatitis C, Rheumatoid and Psoriatic Arthritis, and Cancer 5

Specialty Medications Now Account for 1/3 of Drug Spend Spending on Specialty Medicines US$Bn 28.9 28.9 12.3 26.8 26.8 25.6 25.6 13.8 13.8 26.1 26.1 25.4 11.1 25.4 11.1 14.3 14.3 8.9 8.9 7.7 7.7 12.5 12.5 6.1 6.1 11.4 11.4 10.4 22.2 9.4 9.4 10.4 22.2 17.9 17.9 11.3 13.0 15.1 15.1 11.3 13.0 24.1 25.6 27.9 32. 22.6 24.1 25.6 27.9 32.6 2010 = 75.8 2011 = 83.3 2012 = 89.5 2013 = 98.1 2014 = 124.1 Oncology Autoimmune HIV Antivirals Multiple Sclerosis Viral Hepatitis Other Specialty Medicines Source: IMS Health, National Sales Perspectives, Dec 2014 Top 10 Specialty Drugs 2014 Rank Drug Name Therapy Class 1 Humira (adalimumab) Inflammatory Conditions 2 Enbrel (etanercept) Inflammatory Conditions 3 Sovaldi (sofosbuvir) Hepatitis C 4 Copaxone (glitiramer) Multiple Sclerosis 5 Tecfidera (dimethyl fumarate) Multiple Sclerosis 6 Avonex (interferon beta-1a) Multiple Sclerosis 7 Atripla (efivirenz/emtricitabine/tenofovir) HIV 8 Gleevec (imatinib) Oncology 9 Revlimid (lenalidomide) Oncology 10 Olysio (simeprevir) Hepatitis C Community Pharmacy Challenges Extensive infrastructure need - technology and resources are needed Complexity of operations comprehensive BI and PA support Access to products manufacturers are limiting access to specialty drugs Clinical outcomes need payers / manufacturers may require clinical outcome reporting Technology need a scalable pharmacy platform which is costly Payer contracts limit ability to fill specialty medications due to network lock out 6

Overcoming Challenges Identify a specialty partner for the short and long term Shorter Term Retail pharmacies keep more specialty patients Fill more specialty Rx s Build specialty patientbase Longer Term Create a value proposition to prescribers Obtain new Pharma revenue streams Increase access to specialty drugs and payer contracts What will bridge the gap? Marketing and Technology An Investment For The Future Specialty is NOT a Pot of GOLD! Specialty Pharmacy is work, it is a commitment you make with a cost for success Accreditation (cost to get accredited) LDD access, getting and keeping access (reporting) Network contracts, will you accept the contract pricing? You get contracted, can you stay contracted? Contract requirements and reporting Specialty needs to be marketed, just because you build it doesn t mean they will come Quality Care Program Successes Obtained prior authorization for Hepatitis C drugs for retail store Coordinated overrides utilizing AWP (Any Willing Provider laws) & AMMO Bill for Medicare Part D and NY Managed Medicaid Refill management Just-in-time inventory management for pharmacy client which helps eliminate the possibility of returns 7

Picking a Partner for Specialty You need to search for a partner that has similar goals and will meet the needs for your investment Consider your commitment to specialty, it is not meant for everyone Your ability to succeed will depend on your investment of both capital and time Select your partner for the long term Hometown Pharmacy Specialty Care Program In Partnership With KloudScript Jonathan Grice, PharmD Hometown Pharmacy Profile Founded in 1996 Family owned & operated 36 Retail Locations 34 Michigan, 2 Indiana Management Team Fred Grice, President Jim Grice, Vice President Anna Rider, Vice President Jon Grice, Director of Retail & Advanced Retail Practice Immunizations & Travel Vaccinations Point of Care Testing Medication Therapy Management Compounding & HRT consultations Durable Medical Equipment Home Medical Equipment Vitamin and Nutritional Supplements Home Delivery Service Compliance Packaging Specialty Pharmacy MISSING PIECE = SPECIALTY! 8

Challenging Times... Blockbuster Brand Patent Cliff Exclusion From Growing SP Pipeline PROFITS Increasing Generic Market Share Getting into Specialty is a MUST! Our Criteria For Specialty Solution Buy or Build? Not attractive High risk, high expense, resource intensive, Lack of scale Select the Right Partner!!! Low risk solution Low upfront capital solution Partner who did not compete with us Partner that will not sellout to a competitor or mass merchant Comprehensive program designed for community pharmacies (not just accidental Specialty RXs) Partnership beyond back office support Aligned for long term growth & success Our Partner... Turn-Key Solution Faster ROI De Minimis Investment Full Services Program Support Operational Compliance & QA Robust Technology Enabled Processes Local Sales & Marketing National Network SCALE FOR PAYOR AND PHARMA! Data Analytics Accreditation 9

Together, We Redefine Specialty Care! PATIENT ENGAGEMENT ACCESS DRUG FULFILLMENT FRAMEWORK PHARMACY PARTNER HUB SERVICES TECHNOLOGY TRAINING Growth Since Launch 500 Performance Metrics (September 2014 to August 2015) 458% 400 300 288% 332% Percent 200 100 0 SCRIPTS REVENUE GROSS PROFIT Our partnership consistently demonstrates that local care benefits patients and prescribers. Together we are earning their business! Together, We Redefine Specialty Care! Questions? 10

11